%0 Journal Article %T The effect of PD-L1 categories-directed pembrolizumab plus chemotherapy for newly diagnosed metastatic non-small-cell lung cancer: a cost-effectiveness analysis %A Wu, Bin %A Lu, Shun %J Translational Lung Cancer Research %D 2020 %B 2020 %9 %! The effect of PD-L1 categories-directed pembrolizumab plus chemotherapy for newly diagnosed metastatic non-small-cell lung cancer: a cost-effectiveness analysis %K %X %U https://tlcr.amegroups.org/article/view/43289 %V 9 %N 5 %P 1770-1784 %@ 2226-4477